Steven Hrycaj, PhD is the technical director of the Immunohistochemistry (IHC) Laboratory and co-director of the Rogel Cancer Center Tissue and Molecular Pathology (TMP) core at the University of ...

Immunohistochemistry (IHC) is a special test used by pathologists to detect specific molecules on cells. It is widely used in ...

By applying a widely available lab technique called immunohistochemistry (IHC) to nearly 400 tumor samples, they found that ...

Therapies like ipilimumab and nivolumab have shown the potential for approaches that direct the patient’s own immune system against tumors. Further advances will require a detailed understanding of ...

IHC: Immunohistochemistry; NSCLC: Non-small-cell lung cancer. Adapted with permission from [77]. The authors have no relevant affiliations or financial involvement with any organization or entity ...

(C-D) Expression of eEF1A2 in GBC tumor tissues and paired normal tissues was examined by western blotting (C) and analyzed with ImageJ (D). (E-F) IHC staining was performed in a GBC microarray ...

A clearer understanding of foci-specific molecular heterogeneity is important, as these molecular differences may prognosticate tumor growth and treatment success. In this presentation, we will ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...